key: cord-0773785-r4wzi3p8 authors: Xia, Qi‐Dong; Xun, Yang; Lu, Jun‐Lin; Lu, Yu‐Chao; Yang, Yuan‐Yuan; Zhou, Peng; Hu, Jia; Li, Cong; Wang, Shao‐Gang title: Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19 date: 2020-11-03 journal: Cell Prolif DOI: 10.1111/cpr.12949 sha: 67e38a7ab9109e2eb67dafde1f083b885fc0322e doc_id: 773785 cord_uid: r4wzi3p8 OBJECTIVES: Coronavirus disease 2019 (COVID‐19) is rapidly spreading worldwide. Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19. This study is aimed to discover its molecular mechanism and provide potential drug targets. MATERIALS AND METHODS: An LQC target and COVID‐19–related gene set was established using the Traditional Chinese Medicine Systems Pharmacology database and seven disease‐gene databases. Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis and protein‐protein interaction (PPI) network were performed to discover the potential mechanism. Molecular docking was performed to visualize the patterns of interactions between the effective molecule and targeted protein. RESULTS: A gene set of 65 genes was generated. We then constructed a compound‐target network that contained 234 nodes of active compounds and 916 edges of compound‐target pairs. The GO and KEGG indicated that LQC can act by regulating immune response, apoptosis and virus infection. PPI network and subnetworks identified nine hub genes. The molecular docking was conducted on the most significant gene Akt1, which is involved in lung injury, lung fibrogenesis and virus infection. Six active compounds of LQC can enter the active pocket of Akt1, namely beta‐carotene, kaempferol, luteolin, naringenin, quercetin and wogonin, thereby exerting potential therapeutic effects in COVID‐19. CONCLUSIONS: The network pharmacological strategy integrates molecular docking to unravel the molecular mechanism of LQC. Akt1 is a promising drug target to reduce tissue damage and help eliminate virus infection. Coronavirus disease 2019 (COVID- 19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). 1 It can lead to fever, fatigue, dry cough, multiple organ dysfunction and death. 2 A total of 216 countries or regions have reported confirmed cases. By 4 September 2020, the number of patients has reached 26 171 112, including at least 1 million deaths. 3 As a public health emergency with international concern, COVID-19 has brought a disastrous impact on the global health system and economic system. 4 However, the drug that can cure SARS-CoV-2 infection is still elusive. China has successfully controlled the domestic epidemic in a short period due to the strict epidemic policy. In this process, traditional Chinese medicine (TCM) has also made a great contribution. 5 A meta-analysis that incorporated 11 studies compared TCM plus western medicine with western medicine alone. 6 The pooled results showed that integrated TCM and western medicine generated a higher overall response rate, higher cure rate, lower severity illness rate and shorter hospital stay. 6 in clinical observation and randomized controlled trials (RCT).. [9] [10] [11] LC is a Chinese patent medicine composed of 13 ingredients. 12 LQC is widely used in preventing and treating viral influenza (eg, H1N1) in China. 12 In the present SARS-CoV-2 pandemic, an RCT with 259 participants found that LQC plus abidor was associated with a higher overall response rate and comparable adverse events than abidor alone in mild cases. 11 Another study developed a quadruple combination therapy including LQC and evaluated its efficacy. 10 After treatment, coagulation disorder in severe COVID-19 infection cases was significantly improved and patients in the combined therapy group had a better prognosis. 10 The cumulative evidence proved the capability of LQC to control SARS-CoV-2 infection. Therefore, the study aims to identify the active components of LQC related to SARS-CoV-2 defence and investigate the key targets of eliminating the infection. Akt is a serine/threonine protein kinase that includes Akt1, Akt2 and Akt3. Recent studies showed that during SARS-CoV-2 infection, Akt is activated in a dose-dependent manner. 13 The PI3K/Akt/ mTOR pathway is also involved in lung injury, 14 lung fibrogenesis 15 and immune cell development. 16 The results indicate that Akt may be a therapeutic target for COVID-19. Network pharmacology is a novel method that integrates computer science and medicine, constructing and visualizing 'multi-gene, multi-target, multi-pathway' interaction network to evaluate the molecular mechanism of drugs. 17 This approach is perfectly suitable for the research of multi-component drug such as TCM due to their complex matrices nature. 18 Molecular docking refers to the process that a small molecular is spatially docked into a macromolecular and can score the complementary value at the binding sites, which is used for structure-based drug design. 19 In this study, we explored the molecular mechanism of the action of LQC in COVID-19 using network pharmacology and molecular docking. We found that Akt1 was a hub gene that LQC primarily regulated, suggesting a novel target for COVID-19 treatment. First, we searched the main ingredients of Lianhua Qingwen capsule in the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database (https://tcmspw.com/) to obtain the active compounds and their target genes. 20 Specifically, we selected the "Herb name" by each ingredient of LQC, respectively. The search results showed a series of compounds in traditional Chinese medicine and their corresponding pharmacokinetic indicators. We filtered active compounds by setting the pharmacokinetic index that the oral bioavailability (OB) was greater than 30% and the drug-like (DL) index was > 0.18. For each active compound, we searched related target genes in TCMSP. An LQC target gene set is acquired after gene symbol annotation under the help of Uniprot (https://www.unipr ot.org/). 21 Then, Seven databases were used to search COVID-19-related genes: Genecards database (https://www.genec ards.org/), 22 OMIM database (https://omim.org/), 23 PharmGkb database (https://www. pharm gkb.org/), 24 TTD database (http://db.idrbl ab.net/ttd/), 25 DrugBank database (https://www.drugb ank.ca/), 26 DisGeNet database (https://www.disge net.org/home/) 27 and PubChem database (https://pubch em.ncbi.nlm.nih.gov/). 28 We established a COVID-19-related gene set by taking a union of the search results. An LQC target and COVID-19-related gene set was obtained by intersecting the LQC target gene set and the COVID-19-related gene set. Based on the LQC target gene set and the COVID-19-related gene set, a compound-target network is constructed by means of Cytoscape version 3.8.0. 29 Enrichment analysis, including gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, was performed to reveal the underlying mechanism through biological processes, cellular components, molecular function and key signalling pathways. The "clusterprofile" package in R software version 3.4.0 was used to performed enrichment analysis. The LQC target and COVID-19-related gene set was used to construct PPI network by using STRING database. 30 We set the parameter as moderate confidence (0.400). The PPI network from STRING was then imported into Cytoscape to investigate the critical subnetwork. We applied two methods to screen the core subnetwork. Firstly, we used CytoNca plugin in Cytoscape to analyse the PPI network. 31 In detail, we filtered genes according to the primary score file calculated by CytoNca that each score of Betweenness, Closeness, Degree, Eigenvector, LAC, network scores was higher than the median value. We constructed a primary subnetwork using the filtered genes. The filter process was conducted again to acquire the final critical subnetwork. Another method we used to screen critical subnetwork was CytoHubba plugin in Cytoscape. This approach was to analyse the top 12 genes in the PPI network and to construct the critical subnetwork without checking the first-stage nodes. The most significant gene from two critical subnetworks was se- Using the TCMSP database, 10 key ingredients of LQC were obtained: Banlangen, Dahuang, Gancao, Guanghuoxiang, Guanzhong, Jinyinhua, Kuxingren, Lianqiao, Yuxingcao and Gancao. A total of 257 drug target genes were gained. Besides, we obtained 42, 5, 1, 87, 11, 33 and 473 COVID-19-related genes from Genecards, OMIM, PharmGkb, TTD, DrugBank, DisGeNet and PubChem database, respectively. After removing duplication and combining the search results, an overall 586 COVID-19-related gene set was acquired ( Figure 1A ). Further, by taking an intersection of the compoundtarget genes and disease-related genes, we finally obtained the LQC target and COVID-19-related gene set ( Figure 1B ). After discovering compound-target disease-related genes, we visualized the compound-target interaction network with 234 nodes and 916 edges by using Cytoscape 3.8.0 ( Figure 2A ). Generally, one gene is targeted by multiple active compounds while one compound can target more than one gene. Among 65 genes, PTGS 2 is the most targeted gene by LQC ingredients. GO enrichment analysis was used to discover the underlying biological processes (BP), cellular components (CC) and molecular functions (MF) of the 65 target genes. By setting the filter as adjusted P-value <0.05 and q-value < 0.05, we obtained 1711 significant enriched GO terms. The top 10 terms were illustrated in Figure 2B . The GO terms suggested that these target genes played an essential role in host defence and response to stress. Additionally, we exhibited 7 GO terms related to virus invasion from the enrichment analysis results as Table 1 , which suggested that these target genes play a significant role in virus infection. KEGG enrichment analysis was performed to discover those pathways enriched by the 65 target genes. The filter was also set as an adjusted P-value <0.05 and q-value < 0.05. A total of 151 KEGG pathways were significantly enriched, which showed that these target genes affected the pathways of bacterial and viral infection, the differentiation of immune cells and signal transduction pathways, as well as a series of important pathological processes such as apoptosis. The bubble plot of the most significant 30 KEGG pathways was shown in Figure 3A and the pathway map of the apoptosis was illustrated in Figure 3B . In addition, we extracted and exported the virus-related pathways as Table 2 , and the pathway map can be acquired in the supplementary file. Protein-protein interaction network derived from STRING database showed that the proteins encoded by these target genes had complex interactions ( Figure 4A , B). We imported PPI network into Cytoscape for further analysis. Finally, two key subnetworks com- We took an intersection of the two key subnetworks ( Figure 6A) and nine genes with their rank of significance. The most significant gene, Akt1, was selected to conduct molecular docking. We then obtained six active compounds targeting Akt1 protein from the compound-target interaction network. The compounds were betacarotene, kaempferol, luteolin, naringenin, quercetin and wogonin. Subsequently, molecular docking indicated that all these six active compounds could easily enter and bind the active pocket of the Akt1 protein as shown in Figure 6B . The docking scores were recorded in Table 3 . Over the past ten months, COVID-19 has rapidly spread around the world. SARS-CoV-2 pandemic is still raging in most countries due to the lack of target drugs. Notably, China, as a country with a population of more than 1.3 billion, has successfully con- We mainly focus on the Akt1 gene as one of the critical nodes in the subnetworks and performed molecular docking between micromolecules and the coded protein. Akt1 is one of the serine/ threonine protein kinases call Akt kinase (Akt1, Akt2 and Akt3). 46 A previous study has shown that overexpressed constitutively active Akt1 can promote viral protein synthesis. 47 Also, activation of the PI3K/Akt pathway is indispensable for coxsackievirus B3 infection. 48 Dominant negative mutant of Akt1 can significantly dampen viral RNA expression and further reduce viral capsid protein expression and viral release. 48 The replication of another coronavirus, Middle East respiratory syndrome coronavirus, can be remarkably inhibited by administrating kinase inhibitors targeting the PI3K/Akt. 49 Collectively, Akt1 could be an ideal target with a broad-spectrum antiviral effect. After molecular docking, six molecules were found to directly interact with Akt1: beta-carotene, kaempferol, luteolin, naringenin, quercetin and wogonin. Among them, kaempferol has proven its protective effect against H9N2 swine influenza virus infection. 50 Quercetin is also a potent antiviral agent F I G U R E 5 Identification of key subnetwork using Cytoscape. A, PPI network and the first filtration by CytoNca, the yellow nodes were screened with each score higher than median. B, Subnetwork constructed by a second filtration via CytoNca. The yellow nodes were screened with a score higher than the median. C, Final key subnetwork screened after two filtrations using CytoNca. D, Key subnetwork of top 12 nodes analysed by CytoHubba We uncovered the potential mechanisms of LQC by employing pharmacology network and molecular docking computational analyses. We believe these findings may aid the global fight against the COVID-19 pandemic. We thank the authors for the development of the drug database and software. The authors declare no conflict of interest. Source data of this study is derived from the public repositories, as indicated in the section of 'Materials and Methods' of the manuscript. All data that support the findings of this study is available from the corresponding author upon reasonable request. Jun-Lin Lu https://orcid.org/0000-0002-3438-0297 Shao-Gang Wang https://orcid.org/0000-0002-3206-1495 Beijing News Network, World Health Organization (WHO) Declared Novel Coronavirus's Epidemic a Global Pandemic, and Guterres Called for Action Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China WHO Coronavirus Disease World Health Organization. WHO Director-General's Opening Remarks at the Media Briefing on COVID-19 -3 Prevention and treatment of COVID-19 using traditional Chinese medicine: a review Efficacy and safety of integrated traditional chinese and western medicine for corona virus disease 2019 (COVID-19): a systematic review and meta-analysis BCG instillation versus radical cystectomy for high-risk NMIBC with squamous/glandular histologic variants National Health Commission of the People's Republic of China. The guideline on diagnosis and treatment of coronavirus disease /0a7bd f12bd 4b46e 5bd28 ca7f9 a7f5e 5ashtml Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019 Observation of therapeutic effect of lianhua qingwen granule combined with Abidor on mild new coronavirus pneumonia Identification of a pharmacological biomarker for the bioassay-based quality control of a thirteen-component TCM formula (Lianhua Qingwen) used in treating influenza A Virus (H1N1) infection Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells Repeated radon exposure induced lung injury and epithelial-mesenchymal transition through the PI3K AKT/mTOR pathway in human bronchial epithelial cells and mice Mechanisms of fibrosis: therapeutic translation for fibrotic disease Akt signaling is critical for memory CD8(+) T-cell development and tumor immune surveillance How can synergism of traditional medicines benefit from network pharmacology? Network-based approaches in pharmacology Molecular docking: challenges, advances and its use in drug discovery perspective TCMSP: a database of systems pharmacology for drug discovery from herbal medicines UniProt: a hub for protein information GeneCards: integrating information about genes, proteins and diseases Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders PharmGKB: a worldwide resource for pharmacogenomic information TTD: therapeutic target database DrugBank 5.0: a major update to the DrugBank database for 2018 DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants PubChem BioAssay: 2017 update Cytoscape: a software environment for integrated models of biomolecular interaction networks STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading Research progress of Chinese herbal medicine Radix isatidis (banlangen). The American journal of Chinese medicine Advance of Radix Isatidis Pharmacological Action and Active Substances Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Advances in biological regulation Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications Altered p38 mitogen-activated protein kinase expression in different leukocytes with increment of immunosuppressive mediators in patients with severe acute respiratory syndrome Signal transduction in SARS-CoV-infected cells SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 The AKT genes and their roles in various disorders Role of phosphatidylinositol 3-kinase (PI3K) and Akt1 kinase in porcine reproductive and respiratory syndrome virus (PRRSV) replication Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent Antiviral potential of ERK/ MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis Kaempferol ameliorates H9N2 swine influenza virus-induced acute lung injury by inactivation of TLR4/MyD88-mediated NF-κB and MAPK signaling pathways Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection-In vitro and in silico biochemical and toxicological screening. Food and chemical toxicology : an international journal published for the British Industrial Structural features of NS3 of Dengue virus serotypes 2 and 4 in solution and insight into RNA binding and the inhibitory role of quercetin Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19) TGF-β Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation Antifibrotic action of Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling pathway in mouse model of pulmonary fibrosis Isoliquiritigenin inhibits TGF-β1-induced fibrogenesis through activating autophagy via PI3K/ AKT/mTOR pathway in MRC-5 cells IL-17A-producing T cells exacerbate fine particulate matter-induced lung inflammation and fibrosis by inhibiting PI3K/Akt/mTOR-mediated autophagy Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Hispolon in Mice, Through Regulating the TLR4/PI3K/Akt/mTOR and Keap1/ Nrf2/HO-1 Pathways, and Suppressing Oxidative Stress-Mediated ER Stress-Induced Apoptosis and Autophagy Kinase AKT controls innate immune cell development and function Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization Akt and STAT5 mediate naïve human CD4+ T-cell early metabolic response to TCR stimulation The AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response Sin1/mTORC2 regulate B cell growth and metabolism by activating mTORC1 and Myc Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) Additional supporting information may be found online in the Supporting Information section.